Vytorin detailed information

Template:Chembox header| Simvastatin and Ezetimibe
Simvastatin Ezetimibe
Other names	Vytorin

WikiDoc Resources for Vytorin detailed information
Articles
Most recent articles on Vytorin detailed information Most cited articles on Vytorin detailed information Review articles on Vytorin detailed information Articles on Vytorin detailed information in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Vytorin detailed information Images of Vytorin detailed information Photos of Vytorin detailed information Podcasts & MP3s on Vytorin detailed information Videos on Vytorin detailed information
Evidence Based Medicine
Cochrane Collaboration on Vytorin detailed information Bandolier on Vytorin detailed information TRIP on Vytorin detailed information
Clinical Trials
Ongoing Trials on Vytorin detailed information at Clinical Trials.gov Trial results on Vytorin detailed information Clinical Trials on Vytorin detailed information at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Vytorin detailed information NICE Guidance on Vytorin detailed information NHS PRODIGY Guidance FDA on Vytorin detailed information CDC on Vytorin detailed information
Books
Books on Vytorin detailed information
News
Vytorin detailed information in the news Be alerted to news on Vytorin detailed information News trends on Vytorin detailed information
Commentary
Blogs on Vytorin detailed information
Definitions
Definitions of Vytorin detailed information
Patient Resources / Community
Patient resources on Vytorin detailed information Discussion groups on Vytorin detailed information Patient Handouts on Vytorin detailed information Directions to Hospitals Treating Vytorin detailed information Risk calculators and risk factors for Vytorin detailed information
Healthcare Provider Resources
Symptoms of Vytorin detailed information Causes & Risk Factors for Vytorin detailed information Diagnostic studies for Vytorin detailed information Treatment of Vytorin detailed information
Continuing Medical Education (CME)
CME Programs on Vytorin detailed information
International
Vytorin detailed information en Espanol Vytorin detailed information en Francais
Business
Vytorin detailed information in the Marketplace Patents on Vytorin detailed information
Experimental / Informatics
List of terms related to Vytorin detailed information

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Ezetimibe/simvastatin (IPA: Template:IPA) is a drug combination used for the treatment of dyslipidemia. It is a combination of ezetimibe (best known as Zetia in the United States) and the statin drug simvastatin (best known as Zocor in the U.S.). The combination preparation is marketed by Merck & Co./Schering-Plough Pharmaceuticals (joint venture) under the trade names Vytorin and Inegy.

Ezetimibe works by reducing the amount of cholesterol that the body absorbs from the food ingested.

Simvastatin is an HMG-CoA reductase inhibitor or statin. It works by blocking an enzyme that is necessary for the body to make cholesterol.

Contraindications

• Acute liver disease
• Pregnancy and breast feeding

Side effects

• Myopathy
• Rhabdomyolysis
• Myalgia
• Pain in extremities, abdomen,
• Angioedema
• Hepatitis
• Eczema
• Fatigue
• Headache
• Influenza, Pharyngitis, sinusitis and upper respiratory tract infection

Interactions

• Cyclosporine
• Danazol
• Protease inhibitors
• Verapamil
• Amiodarone
• Large amounts of niacin (nicotinic acid), grapefruit juice
• Erythromycin, telithromycin, clarithromycin
• Nefadozone

External links

• Vytorin Prescription Information Sheet
• Vytorin's Official Site
• Vytorin Information Sheet
• C10BA02 (WHO)

Template:WikiDoc Sources